Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. (2021)
Attributed to:
Joint Wellcome and MRC Centre, ‘Wellcome Trust – Medical Research Council Cambridge Stem Cell Institute’
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.immuni.2021.05.010
PubMed Identifier: 34051148
Publication URI: http://europepmc.org/abstract/MED/34051148
Type: Journal Article/Review
Volume: 54
Parent Publication: Immunity
Issue: 6
ISSN: 1074-7613